Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
FP12 - Tumor Biology and Systems Biology - Basic and Translational Science
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Type: Posters (Featured)
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
-
+
FP12.03 - SRC-Homology 2 Domain-Containing Phosphatase 2 (SHP2) in Resected Lung Adenocarcinoma (LUAD)
00:00 - 00:00 | Presenter: Masaoki Ito
- Abstract
Loading...
-
+
P61 - Tumor Biology and Systems Biology - Basic and Translational Science - KRAS
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
-
+
P61.01 - Imipramine Blue (IP) plus MET Tyrosine Kinase Inhibitors (TKI) Suppress Lung Adenocarcinoma (LUAD) KRAS Mutation Tumor Growth
00:00 - 00:00 | Presenter: Rafael Rosell
- Abstract
Loading...
-
+
P65 - Tumor Biology and Systems Biology - Basic and Translational Science - NC RNA
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
-
+
P65.04 - Tracking circRNAs in Lung Adenocarcinoma Samples as Promising Biomarkers for Cancer Detection using the NanoString nCounter®
00:00 - 00:00 | Presenter: Carlos Pedraz-Valdunciel
- Abstract
Loading...
-
+
MA09 - Prognosis and Staging
- 09:15 - 10:15
- 1/31/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Staging
-
+
MA09.09 - Positive EGFR Mutation Status is a Risk of Recurrence in pN0–1 Lung Adenocarcinoma When Considering pStage and Histological Subtype
09:45 - 09:50 | Presenter: Masaoki Ito
- Abstract
Loading...
